|
⚲
|
| Keyboard |
| Advent Venture Partners LLP
✚
|
|
|---|---|
| CRD # | 163394 |
| SEC # | 802-75258 |
| CIK # | 0001285114 |
| AUM | |
| Employees | |
| Phone | 44207911 |
| Address | 25 Buckingham Gate London, United Kingdom |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Advent Private Equity Fund II | 2012-03-29 | 9.2 M | |
| VC | Advent Private Equity Fund III | 2012-03-29 | 145.9 M | |
| VC | Advent Private Equity Fund IV | 2012-03-29 | 250.3 M |
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001285114] | |
| 4 | [0001285114] | |
| SC 13G | [0001285114] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Advent Venture Partners LLP | Conatus Pharmaceuticals Inc | [2014-02-13] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Advent Venture Partners LLP | |
| Histogen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Conversion | 1,888,091 | ||
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Option exercise | 70,003 | $0.08 | 5,600 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Buy | 190,054 | $11.00 | 2,090,594 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Other | 19,223 | $11.00 | 211,453 |
|
Histogen Inc CNAT
Common Stock
|
2013-07-30 | Sell | 535 | $11.00 | 5,885 |
|
Histogen Inc CNAT
Series A Preferred Stock · derivative
|
2013-07-30 | Conversion | 10,000,000 | ||
|
Histogen Inc CNAT
Series B Preferred Stock · derivative
|
2013-07-30 | Conversion | 5,576,786 | ||
|
Histogen Inc CNAT
Warrants to Purchase Shares of Series A Preferred Stock · derivative
|
2013-07-30 | Option exercise | 577,599 |